Roivant Sciences President & Vant Chair Reports Tax Withholding Transaction

Executive Summary

On September 30, 2026, Frank Torti, President and Vant Chair of Roivant Sciences Ltd. ($ROIV), reported a transaction involving 40,309 common shares at a price of $36.57 per share, totaling approximately $1,474,100.13. Following this transaction, Torti directly holds 13,495,893 common shares of the company.

Transaction Details

• Security: Common Shares
• Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities)
• Context: As noted in the filing, this transaction reflects the net settlement of restricted stock units (RSUs) by the issuer to satisfy tax withholding obligations upon vesting.
• Direct/Indirect Ownership: Direct ownership remains substantial at over 13.49 million shares.

Market Impact & Significance

The filing indicates low trading significance. Code 'F' transactions are automated or mandatory non-market dispositions/settlements aimed at satisfying statutory tax liabilities rather than discretionary open-market buying or selling. The transaction does not reflect changes in executive sentiment regarding the company's operational or financial prospects.